These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6112587)

  • 21. Presence of tau pathology within foetal neural allografts in patients with Huntington's and Parkinson's disease.
    Cisbani G; Maxan A; Kordower JH; Planel E; Freeman TB; Cicchetti F
    Brain; 2017 Nov; 140(11):2982-2992. PubMed ID: 29069396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia.
    Bird ED; Iversen LL
    Brain; 1974 Sep; 97(3):457-72. PubMed ID: 4157009
    [No Abstract]   [Full Text] [Related]  

  • 23. Regional distribution of choline acetyltransferase in the human brain: changes in Huntington's chorea.
    Aquilonius SM; Eckernås SA; Sundwall A
    J Neurol Neurosurg Psychiatry; 1975 Jul; 38(7):669-77. PubMed ID: 125784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington's disease.
    Boussicault L; Alves S; Lamazière A; Planques A; Heck N; Moumné L; Despres G; Bolte S; Hu A; Pagès C; Galvan L; Piguet F; Aubourg P; Cartier N; Caboche J; Betuing S
    Brain; 2016 Mar; 139(Pt 3):953-70. PubMed ID: 26912634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DOPA as anti-metabolite in Huntington's disease.
    Shokeir MH
    Lancet; 1973 May; 1(7810):1005-6. PubMed ID: 4121569
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of glutamine synthetase in the central nucleus of the amygdala induces anhedonic behavior and recurrent seizures in a rat model of mesial temporal lobe epilepsy.
    Gruenbaum SE; Wang H; Zaveri HP; Tang AB; Lee TS; Eid T; Dhaher R
    Epilepsy Behav; 2015 Oct; 51():96-103. PubMed ID: 26262937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Congenital glutamine deficiency with glutamine synthetase mutations.
    Häberle J; Görg B; Rutsch F; Schmidt E; Toutain A; Benoist JF; Gelot A; Suc AL; Höhne W; Schliess F; Häussinger D; Koch HG
    N Engl J Med; 2005 Nov; 353(18):1926-33. PubMed ID: 16267323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical abnormalities in Huntington's chorea brains.
    Stahl WL; Swanson PD
    Neurology; 1974 Sep; 24(9):813-9. PubMed ID: 4277376
    [No Abstract]   [Full Text] [Related]  

  • 29. Regional and subcellular distribution of superoxide dismutase in brain.
    Loomis TC; Yee G; Stahl WL
    Experientia; 1976 Nov; 32(11):1374-6. PubMed ID: 136361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Huntington's chorea: selective depletion of activity of angiotensin coverting enzyme in the corpus striatum.
    Arregui A; Bennett JP; Bird ED; Yamamura HI; Iversen LL; Snyder SH
    Ann Neurol; 1977 Oct; 2(4):294-8. PubMed ID: 214022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of glutamine synthetase during ammonia exposure in rainbow trout indicates a high reserve capacity to prevent brain ammonia toxicity.
    Sanderson LA; Wright PA; Robinson JW; Ballantyne JS; Bernier NJ
    J Exp Biol; 2010 Jul; 213(Pt 13):2343-53. PubMed ID: 20543133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Huntington's disease: changes in tachykinin content in postmortem brains.
    Arai H; Emson PC; Carrasco LH
    Ann Neurol; 1987 Nov; 22(5):587-94. PubMed ID: 2447825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enzymes associated with the metabolism of catecholamines, acetylcholine and gaba in human controls and patients with Parkinson's disease and Huntington's chorea.
    McGeer PL; McGeer EG
    J Neurochem; 1976 Jan; 26(1):65-76. PubMed ID: 3629
    [No Abstract]   [Full Text] [Related]  

  • 34. Autopsy case of concurrent Huntington's disease and neurofibromatosis type 1.
    Kawakami I; Katsuse O; Aoki N; Togo T; Suzuki K; Isojima D; Kondo D; Iseki E; Kosaka K; Akiyama H; Hirayasu Y
    Psychogeriatrics; 2014 Mar; 14(1):81-6. PubMed ID: 24528652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of post-mortem delay on N-terminal huntingtin protein fragments in human control and Huntington disease brain lysates.
    Schut MH; Patassini S; Kim EH; Bullock J; Waldvogel HJ; Faull RLM; Pepers BA; den Dunnen JT; van Ommen GB; van Roon-Mom WMC
    PLoS One; 2017; 12(6):e0178556. PubMed ID: 28570578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inborn error of amino acid synthesis: human glutamine synthetase deficiency.
    Häberle J; Görg B; Toutain A; Rutsch F; Benoist JF; Gelot A; Suc AL; Koch HG; Schliess F; Häussinger D
    J Inherit Metab Dis; 2006; 29(2-3):352-8. PubMed ID: 16763901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Huntington's disease: Neural dysfunction linked to inositol polyphosphate multikinase.
    Ahmed I; Sbodio JI; Harraz MM; Tyagi R; Grima JC; Albacarys LK; Hubbi ME; Xu R; Kim S; Paul BD; Snyder SH
    Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9751-6. PubMed ID: 26195796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of immunoreactive glutamine synthetase in the adult human and mouse brain. Qualitative and quantitative observations with special emphasis on extra-astroglial protein localization.
    Bernstein HG; Bannier J; Meyer-Lotz G; Steiner J; Keilhoff G; Dobrowolny H; Walter M; Bogerts B
    J Chem Neuroanat; 2014 Nov; 61-62():33-50. PubMed ID: 25058171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in the neurochemistry of Huntington's disease.
    Wastek GJ; Stern LZ; Yamamura HI
    Ariz Med; 1977 Aug; 34(8):547-8. PubMed ID: 143259
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurochemical findings in Huntington's chorea.
    Bird ED; Iversen LL
    Essays Neurochem Neuropharmacol; 1977; 1():177-95. PubMed ID: 152197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.